Is Healthpeak Properties Stock Underperforming the Dow?
Prominent Wall Street short sellers: Investors should focus on defensive stocks earnings and wait for clearer employment data.
Morgan Stanley maintains a neutral stance on defensive stocks related to cyclical sectors in the economy, waiting for 'clearer' employment data. The bank believes employment data is a key driving factor for the year-end stock market.
JPMorgan Adjusts Price Target on Healthpeak Properties to $24 From $21, Maintains Neutral Rating
J.P. Morgan Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $24
J.P. Morgan analyst Michael Mueller maintains $Healthpeak Properties(DOC.US)$ with a hold rating, and adjusts the target price from $21 to $24.According to TipRanks data, the analyst has a success
Best Real Estate Growth Stocks as the Sector Is Seeing a Revival
Express News | Healthpeak Properties Inc : Evercore ISI Raises Target Price to $26 From $25
Evercore Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $26
Evercore analyst James Kammert maintains $Healthpeak Properties(DOC.US)$ with a buy rating, and adjusts the target price from $25 to $26.According to TipRanks data, the analyst has a success rate of 8
How the 10-year Yield Affects REITs
Is It a Wise Decision to Hold Healthpeak Properties Stock Now?
Scotiabank Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $24
Scotiabank analyst Nicholas Yulico maintains $Healthpeak Properties(DOC.US)$ with a buy rating, and adjusts the target price from $22 to $24.According to TipRanks data, the analyst has a success
Scotiabank Reaffirms Their Buy Rating on Healthpeak Properties (DOC)
Scotiabank Adjusts Healthpeak Properties Price Target to $24 From $23
Real Estate Stocks Start One of the Worst Months for Equities on a Strong Note
Looking Into Healthpeak Properties's Recent Short Interest
Real Estate Stocks Surge in August, Set to Rebound After Underperformance
Healthpeak Properties' Stock Rises 31% in 6 Months: Here's How
Healthpeak Properties Is Maintained at Outperform by Evercore ISI Group
Healthpeak Properties Analyst Ratings
Express News | Healthpeak Properties Inc : Morgan Stanley Resumes Coverage With Equal-Weight Rating; Price Target $23.5
Evercore Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $25
Evercore analyst James Kammert maintains $Healthpeak Properties(DOC.US)$ with a buy rating, and adjusts the target price from $24 to $25.According to TipRanks data, the analyst has a success rate of 7